Avanos Medical, Inc.
Avanos Medical, Inc. (AVNS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AVNS · as of Jun 8, 2026
Key Statistics
Explore Avanos Medical, Inc. Data
avns stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 12.5%
The AVNS analyst consensus is Hold, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $23.00, representing -8.18% downside from the current price of $25.05.
Competitors & Peers
avns competitorsAVNS
BCYC
BVS
CBLL
CLPT
CTKBStock Performance
Full HistoryAbout Avanos Medical, Inc.
Avanos Medical, Inc. a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a p…
what is avanos medical, inc. · avns stock overview · avanos medical, inc. company profile · who is avanos medical, inc. ceo · avns NYSE · avanos medical, inc. headquarters · avanos medical, inc. business segments
About Stock Overview & Key Data
Avanos Medical, Inc. (AVNS) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Oct 21, 2014. As of the latest trading session, AVNS stock price is $25.05, with a market capitalization of $1.2B. The stock has returned +98.18% over the past 12 months and +123.06% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Avanos Medical, Inc. stock is Hold, with an average 12-month price target of $23.00. In fiscal year 2025, Avanos Medical, Inc. reported revenue of $701.2M and net income of -$67.9M. For detailed data — including Avanos Medical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Avanos Medical, Inc. (AVNS) stock price is $25.05. The stock is traded on NYSE under the ticker symbol AVNS. The 52-week range is $9.30 – $25.49.